Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients

Not yet recruiting

• Conditions: Chronic Kidney Disease(CKD); Depression

• Registration Number: NCT06675396
• Lead Sponsor: Wonju Severance Christian Hospital

Brief Summary

By using genetic information we could predict the prevalence of mood disorder and response to treatment.

Detailed Description

This prospective cohort study enrols patients with chronic kidney disease and gathers genetic information. By the patient's biochemical information, including genetic information, we could predict the prevalence of mood disorder and response to the antipsychotherapy.

Study Timeline

• Status Verified: 2024-11
• Study First Submitted: 2024-11-04
• Study First Submitted QC: 2024-11-04
• Last Update Submitted: 2024-11-04
• Study First Posted: 2024-11-05
• Last Update Posted: 2024-11-05
• Study Start: 2024-12-01
• Primary Completion: 2026-12-31
• Study Completion: 2028-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• CKD patients aged 18 to 90 years

Exclusion Criteria

• no CKD patients, aged below 18 or above 90 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of depression	10 years	Prevalence of depression